Live Oak Private Wealth LLC Has $10.05 Million Position in Danaher Co. (NYSE:DHR)

Live Oak Private Wealth LLC boosted its stake in shares of Danaher Co. (NYSE:DHR) by 5.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,789 shares of the conglomerate’s stock after purchasing an additional 2,151 shares during the quarter. Danaher comprises approximately 1.7% of Live Oak Private Wealth LLC’s investment portfolio, making the stock its 15th biggest position. Live Oak Private Wealth LLC’s holdings in Danaher were worth $10,052,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Heck Capital Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter worth $27,000. Decker Retirement Planning Inc. acquired a new stake in Danaher in the 4th quarter worth about $31,000. Strategic Financial Concepts LLC bought a new stake in Danaher in the 4th quarter valued at about $31,000. Teachers Insurance & Annuity Association of America acquired a new position in shares of Danaher during the 3rd quarter worth approximately $39,000. Finally, MidAtlantic Capital Management Inc. bought a new position in shares of Danaher during the third quarter worth approximately $40,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a research note on Friday, December 13th. Robert W. Baird decreased their price objective on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. JPMorgan Chase & Co. cut their target price on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Stephens reiterated an “overweight” rating and issued a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. Finally, Scotiabank started coverage on Danaher in a research report on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price objective for the company. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Price Performance

Shares of NYSE:DHR opened at $209.95 on Friday. The firm has a market cap of $151.64 billion, a PE ratio of 39.76, a price-to-earnings-growth ratio of 2.80 and a beta of 0.83. Danaher Co. has a 52 week low of $209.10 and a 52 week high of $281.70. The firm’s fifty day moving average is $233.96 and its 200-day moving average is $252.39. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the firm posted $2.09 EPS. Sell-side analysts predict that Danaher Co. will post 7.77 earnings per share for the current year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were issued a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.51%. Danaher’s payout ratio is 20.45%.

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 10.90% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.